|
DVGDAYFSVPLDKDFRKY
|
Pol(265-282)
|
human epitope
|
AYFSVPLDKDFRKYT
|
Pol(269-283)
|
C*07:02 human epitope
|
YFSVPLDEGFRKYTA
|
Pol(270-284)
|
human epitope
|
YFSVPLDEGFRKYTA
|
Pol(270-284)
|
human epitope
|
YFSVPLDEGFRKYTA
|
Pol(270-284)
|
human epitope
|
FSVPLDEDFRKYTAFTIPSI
|
Pol(271-290)
|
human epitope
|
SVPLDKDFRKYTAFTI
|
Pol(272-287)
|
human epitope
|
SVPLDeDFRKYTAFTI
|
Pol(272-287)
|
non-susceptible form
|
VPLDEDFRKY
|
Pol(273-282)
|
A*03 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*15:02 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35 human epitope
|
iPLDEDFRKY
|
Pol(273-282)
|
HLA association; non-susceptible form; susceptible form
|
VPLDkDFRKY
|
Pol(273-282)
|
observed variant
|
VPLDkxFRKY
|
Pol(273-282)
|
observed variant
|
VPLDEnFRKY
|
Pol(273-282)
|
observed variant
|
VPLDxxFRKY
|
Pol(273-282)
|
observed variant
|
VPLDEDFRKY
|
Pol(273-282)
|
B35 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B35 human epitope
|
VPLhEDFRKY
|
Pol(273-282)
|
non-susceptible form
|
VPLDkDFRKY
|
Pol(273-282)
|
non-susceptible form
|
VPhDEDFRKY
|
Pol(273-282)
|
non-susceptible form
|
VPLDKDFRKY
|
Pol(273-282)
|
B35 human epitope
|
VPLDKeFRKY
|
Pol(273-282)
|
susceptible form
|
VPLDEDFRKY
|
Pol(273-282)
|
B35 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01, B35 human epitope
|
VPLDEGFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDkDFRKY
|
Pol(273-282)
|
susceptible form
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEGFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
B*35:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*35:02, B*35:03, B*53:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
B*42:01 human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
C*14 human epitope
|
VPLDKDFRKY
|
Pol(273-282)
|
human epitope
|
VPLDeDFRKY
|
Pol(273-282)
|
observed variant
|
VPLDEDFRKY
|
Pol(273-282)
|
human epitope
|
VPLDEDFRKY
|
Pol(273-282)
|
human epitope
|
VPLDKDFRKYTAFTI
|
Pol(273-287)
|
C*07:02 human epitope
|
VPLDKEFRKYTAFTIPSI
|
Pol(273-290)
|
human epitope
|
VPLDKDFRKYTAFTIPSI
|
Pol(273-290)
|
human epitope
|
PLDEGFRKY
|
Pol(274-282)
|
B*35:01 human epitope
|
PLDESFRKY
|
Pol(274-282)
|
human epitope
|
PLDEDFRKY
|
Pol(274-282)
|
human epitope
|
PLDEGFRKYTAFTIP
|
Pol(274-288)
|
human epitope
|
PLDEGFRKYTAFTIP
|
Pol(274-288)
|
human epitope
|
PLDEGFRKYTAFTIP
|
Pol(274-288)
|
human epitope
|
GFRKYTAFTIPSINN
|
Pol(278-292)
|
human epitope
|
GFRKYTAFTIPSINN
|
Pol(278-292)
|
human epitope
|
GFRKYTAFTIPSINN
|
Pol(278-292)
|
human epitope
|
KYTAFTIPSI
|
Pol(281-290)
|
A*02:01 human epitope
|
KYTAFTIPSI
|
Pol(281-290)
|
A2 human epitope
|
KYTAFTIPSI
|
Pol(281-290)
|
human epitope
|
KYTAFTIPSINNETP
|
Pol(281-295)
|
human epitope
|
KYTAFTIPSINNETPGIR
|
Pol(281-298)
|
human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02 human epitope
|
YTAFTIPSv
|
Pol(282-290)
|
observed variant
|
YTAFTIPSV
|
Pol(282-290)
|
A*02 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02:01 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02:05 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02:06 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02:06 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*02:06 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*11 human epitope
|
YTAFTIPSV
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSV
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSV
|
Pol(282-290)
|
A2 human epitope
|
YTAFTIPSi
|
Pol(282-290)
|
diminished response
|
YTAFTIPSI
|
Pol(282-290)
|
A2 supertype human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
A*66 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
B*35:02, B*35:03, B*53:01 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
B*51 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
C*01 human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
human epitope
|
YTAFTIPSI
|
Pol(282-290)
|
human epitope
|
YTAFTIPSINNETPG
|
Pol(282-296)
|
human epitope
|
YTAFTIPSINNETPG
|
Pol(282-296)
|
human epitope
|
YTAFTIPSINNETPG
|
Pol(282-296)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*02:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*02:01, B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*02:17, B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*23 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*24 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
A*66 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*35:02, B*35:03, B*53:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*40 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished HLA binding or increased off-rate
|
TAFTIPSr
|
Pol(283-290)
|
diminished HLA binding or increased off-rate
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSl
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSv
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSt
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSr
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSV
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSi
|
Pol(283-290)
|
|
TAFTIPSl
|
Pol(283-290)
|
diminished HLA binding or increased off-rate; susceptible form
|
TAFTIPSt
|
Pol(283-290)
|
diminished HLA binding or increased off-rate
|
TAFTIPSr
|
Pol(283-290)
|
non-susceptible form
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
calculated escape
|
TAFTIPSm
|
Pol(283-290)
|
observed variant
|
TAFTIPSr
|
Pol(283-290)
|
observed variant
|
TAFTvPSt
|
Pol(283-290)
|
observed variant
|
TAFTIPSI
|
Pol(283-290)
|
B*51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51, B*52 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
susceptible form
|
TAFTIPSv
|
Pol(283-290)
|
susceptible form
|
TvFTIPSI
|
Pol(283-290)
|
non-susceptible form
|
TAFTIPSt
|
Pol(283-290)
|
diminished response
|
TAFTIPSv
|
Pol(283-290)
|
diminished response
|
TvFTIPSt
|
Pol(283-290)
|
diminished response
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished response; susceptible form
|
TAFTIPSm
|
Pol(283-290)
|
diminished response; susceptible form
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B51 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSv
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished response
|
TAFTIPSr
|
Pol(283-290)
|
diminished response
|
TAFTIPSv
|
Pol(283-290)
|
diminished response
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
TAFTIPSr
|
Pol(283-290)
|
diminished HLA binding or increased off-rate; escape documented in this paper
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished response; escape documented in this paper; non-susceptible form
|
TAFTIPSv
|
Pol(283-290)
|
diminished response; escape documented in this paper; non-susceptible form
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSx
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSt
|
Pol(283-290)
|
calculated diminished HLA binding; observed variant
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
diminished response
|
TAFTIPSr
|
Pol(283-290)
|
diminished response
|
TAFTIPSv
|
Pol(283-290)
|
diminished response
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSv
|
Pol(283-290)
|
diminished response
|
TAFTIPSr
|
Pol(283-290)
|
diminished response
|
TAFTIPSt
|
Pol(283-290)
|
diminished response
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TvFTIPSI
|
Pol(283-290)
|
observed variant
|
TAFTIPSt
|
Pol(283-290)
|
observed variant
|
TAFTIPSv
|
Pol(283-290)
|
observed variant
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSr
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSl
|
Pol(283-290)
|
escape documented in this paper
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
B*51:01, B*52:01 human epitope
|
TAFTIPSt
|
Pol(283-290)
|
observed variant
|
TAFTIPSl
|
Pol(283-290)
|
observed variant
|
TAFTIPSv
|
Pol(283-290)
|
observed variant
|
TAFTIPSr
|
Pol(283-290)
|
observed variant
|
TAFTIPSm
|
Pol(283-290)
|
observed variant
|
TAFTIPSI
|
Pol(283-290)
|
B*52:01 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
C*12 human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSI
|
Pol(283-290)
|
human epitope
|
TAFTIPSv
|
Pol(283-290)
|
escape documented in this paper; replicative capacity reduced; susceptible form
|
TAFTvPSv
|
Pol(283-290)
|
escape documented in this paper; susceptible form
|
TAFTIPSIN
|
Pol(283-291)
|
human epitope
|
FTIPSINNETPGIRY
|
Pol(285-299)
|
A25 human epitope
|
TIPSINNETPGIRYQ
|
Pol(286-300)
|
human epitope
|
TIPSINNETPGIRYQ
|
Pol(286-300)
|
human epitope
|
IPSTNNETPG
|
Pol(287-296)
|
B7 human epitope
|
PSINNETPG
|
Pol(288-296)
|
human epitope
|
STNNETPGVRY
|
Pol(289-299)
|
B*18 human epitope
|
SINNETPGIRYQYNVLPQ
|
Pol(289-306)
|
human epitope
|
INNETPGIRYQYNVL
|
Pol(290-304)
|
human epitope
|